NCT00616824

Brief Summary

This study intends to compare postoperative outcomes of a tissue expander placement following a mastectomy with two different operative techniques. This study will be randomized and double blinded comparing the traditional placement of the tissue expander under an inferolateral serratus muscle flap to a new technique which uses an acellular dermal matrix as an inferolateral sling, instead of the muscle flap. The study we are proposing will evaluate the question of whether there is a difference between the traditional method of serratus flap and the new technique of using an acellular matrix with tissue expander placement. This will be a double blinded randomized study of thirty women in each group comparing outcomes which will include postoperative pain, complications (wound infection, hematoma, capsular contracture, etc), and patient satisfaction with the procedure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2007

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 15, 2008

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

April 4, 2017

Status Verified

March 1, 2017

Enrollment Period

2.5 years

First QC Date

February 5, 2008

Last Update Submit

March 30, 2017

Conditions

Keywords

Acellular dermal matrixbreast reconstructiontissue expanderpostoperative paincomplicationpainpatient satisfaction

Outcome Measures

Primary Outcomes (1)

  • postoperative pain

    perioperative up to 1 year

Secondary Outcomes (3)

  • aesthetic outcome

    1 year

  • complications (infection, hematoma, capsular contracture)

    1 year

  • Patient satisfaction

    1 year

Study Arms (2)

Traditional Method

ACTIVE COMPARATOR

Arm which uses the Serratus Anterior muscle mobilization for lateral coverage of the tissue expander

Procedure: Serratus anterior to cover lateral aspect of tissue expander

Dermamatrix Arm

EXPERIMENTAL

Arm which uses Dermamatrix as the lateral expander coverage

Procedure: Dermamatrix to cover lateral aspect of tissue expander

Interventions

Dermamatrix used to cover lateral aspect of breast tissue expander after mastectomy

Also known as: Dermamatrix
Dermamatrix Arm

Traditional use of serratus anterior for coverage of lateral aspect of tissue expander

Traditional Method

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients presenting to Dr. Wendel's clinic who are older than 17 years of age undergoing a mastectomy and wish to have breast reconstruction with a tissue expander or those who have previously undergone a mastectomy and are now seeking reconstruction will be solicited for the study.

You may not qualify if:

  • Preoperative radiation therapy
  • Autoimmune disease
  • Fever
  • Uncontrolled diabetes mellitus
  • Inability to comprehend or cooperate with postoperative instructions
  • Local or systemic infection
  • Have any allergies to the excipient ingredients found in the matrix
  • Pregnancy
  • Low vascularity of the surrounding tissue
  • Mechanical trauma
  • Poor nutrition
  • Poor general medical condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37232-2345, United States

Location

MeSH Terms

Conditions

Pain, PostoperativePainPatient Satisfaction

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsSigns and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jason J. Wendel, M.D.

    Vanderbilt University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2008

First Posted

February 15, 2008

Study Start

September 1, 2007

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

April 4, 2017

Record last verified: 2017-03

Locations